Clinical trial
A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine…
NCT00427830 · University of Oxford, Other · Completed
Key facts
| NCT number | NCT00427830 |
|---|---|
| Title | A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Previously Received BCG |
| Official title | A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Previously Received BCG |
| Lead sponsor | University of Oxford, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Tuberculosis |
| Intervention type | Biological |
| Interventions | MVA85A |
| Enrollment | 16 |
| Start date | May 1, 2003 |
| Completion | Jan 1, 2005 |
| First posted | Jan 29, 2007 |
| Last update posted | Jan 29, 2007 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: